Clinical Trials · NCT07091734
Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- University of Michigan
- Enrollment
- 32
- Start date
- Sep 2025
- Locations
- 1 site, United States
- Primary endpoint
- Change in Body Mass Index (BMI) from baseline in Group A (Tirzepatide-treated) versus Group B (control) at 24 weeks